natco pharma semaglutide launches Rs 1,290 in India, undercuts diabetes drug prices Indian pharma launches low-cost Ozempic

This study found that semaglutide did not meaningfully change the AUC of omeprazole (AUC ratio 0.88, 90% CI: 0.73 to 1.06), though peak concentration (Cmax) was reduced by approximately 24% (Jordy et al., Clin Pharmacokinet, 2021) [7]

This advanced treatment delivers a potent blend of collagen, hyaluronic acid, vitamin C, and CoQ10 directly into the bloodstream, supporting skin hydration, elasticity, and antioxidant protection from the inside out

However, no completed trial has examined the effect of GLP-1 RAs on cardiovascular events in patients with established CVD and overweight/obesity in the absence of type 2 diabetes

Some people may experience mild side effects like nausea and constipation, but these often decrease as your body adjusts to the medication